MAY022023_01B3203Decided 2023-05-02I-140

AAO dismissed an EB-1B petition for an analytical chemist, finding that while she met three evidentiary criteria, the…

Dismissed Useful for: avoid these mistakes
EB-1BField: analytical chemistry
The outcome

This appeal was not successful at this stage

The AAO dismissed the appeal, finding that while the Beneficiary met the initial evidentiary criteria, the totality of the record did not establish that she is internationally recognized as outstanding in her academic field of analytical chemistry.

In plain English

A pharmaceutical company petitioned to classify an analytical chemist as an outstanding researcher under EB-1B. The Director denied the petition after finding three criteria met but concluding the final merits standard was not satisfied. On appeal, the AAO agreed, finding that expert letters were too vague and conclusory, citation evidence was inadequately contextualized, editorial board membership was unsupported by documentation, and conference invitation emails without proof of attendance did not demonstrate international recognition. The AAO dismissed the appeal, holding that the totality of the evidence did not show the Beneficiary is internationally recognized as outstanding in analytical chemistry.

What worked & what failed

What worked: The Beneficiary satisfied three of the six EB-1B evidentiary criteria — judging/peer review, original scientific contributions, and scholarly articles — clearing the initial threshold.

What failed: Expert opinion letters were too conclusory and lacked detailed explanations of significance. Citation count evidence was not properly contextualized within the specific field of analytical chemistry. Claims of editorial board roles and conference presentations were not corroborated by documentary evidence of actual activity or attendance.

Takeaway: For EB-1B petitions, meeting the initial criteria threshold is not enough — petitioners must build a robust record of international recognition through well-documented, field-specific evidence. Expert letters should provide detailed, specific explanations of significance, citation evidence should be benchmarked within the relevant field, and any claimed roles (e.g., editorial board) must be corroborated with concrete documentary proof.

For RFE responses & petition building

Cases like this are frequently used by attorneys when responding to RFEs or building initial petitions. The evidence patterns that worked (or failed) here directly reflect what USCIS officers look for when evaluating EB-1B criteria.

Evidence that moved the needle

  • The Beneficiary satisfied three of the six EB-1B evidentiary criteria — judging/peer review, original scientific contributions, and scholarly articles — clearing the initial threshold.

Evidence that wasn't enough alone

  • Expert opinion letters were too conclusory and lacked detailed explanations of significance
  • Citation count evidence was not properly contextualized within the specific field of analytical chemistry
  • Claims of editorial board roles and conference presentations were not corroborated by documentary evidence of actual activity or attendance.
Find more EB-1B cases with similar evidence patterns →
What the evidence showed

Criterion-by-criterion breakdown

Judging the work of others

Met

Director found criterion met for participation as a judge/peer reviewer of the work of others; AAO acknowledged this but found it insufficient to demonstrate international recognition at final merits stage

Original contributions of major significance

Met

Director found criterion met for original scientific research contributions; AAO found expert letters too conclusory and citation evidence insufficient to show international recognition at final merits stage

Authorship of scholarly articles

Met

Director found criterion met for authorship of scholarly articles; publication record acknowledged but found insufficient to demonstrate international recognition

How the case moved

Completed

I-140 filed

Researcher and director of analytical chemistry at a pharmaceutical company

Completed

Director — Denied

Initial decision: Denied.

Completed

Appeal to the AAO

Petitioner appealed to the Administrative Appeals Office for de novo review.

2023-05-02

AAO decision — Dismissed

The AAO dismissed the appeal, finding that while the Beneficiary met the initial evidentiary criteria, the totality of the record did not establish that she is internationally recognized as outstanding in her academic field of analytical chemistry.

If you're appealing a similar decision, I-290B must be filed within 30 days of personal service of the denial, or 33 days if mailed.

Authorities the office relied on
ChawathePetitioner bears the burden of proof to demonstrate eligibility by a preponderance of the evidence
Christo'sAAO reviews questions de novo
Matter of S-A-Testimony should not be disregarded simply because it is self-serving, but corroborative evidence is required where available
Matter of Y-B-If testimonial evidence lacks specificity, detail, or credibility, there is a greater need for corroborative evidence